ENTRADA THERAPEUTICS, INC. Effective Income Tax Rate Reconciliation, Other Adjustments, Percent
ENTRADA THERAPEUTICS, INC. (TRDA) reported Effective Income Tax Rate Reconciliation, Other Adjustments, Percent of 0.00% for the 12-month period ending 2024-12-31, per its 10-K filed 2025-02-27.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments · last filed 2025-02-27
- ENTRADA THERAPEUTICS, INC. effective income tax rate reconciliation, other adjustments, percent for fiscal 2024 was 0.00%.
- ENTRADA THERAPEUTICS, INC. effective income tax rate reconciliation, other adjustments, percent for fiscal 2023 was -2.00%.
- ENTRADA THERAPEUTICS, INC. effective income tax rate reconciliation, other adjustments, percent for fiscal 2022 was 0.00%.
| Period end | Effective Income Tax Rate Reconciliation, Other Adjustments, Percent 12 month | Effective Income Tax Rate Reconciliation, Other Adjustments, Percent 12 month as first filed |
|---|---|---|
| 2024-12-31 | 0.00% 10-K · filed 2025-02-27 | |
| 2023-12-31 | -2.00% 10-K · filed 2025-02-27 | -1.90% 10-K · filed 2024-03-13 |
| 2022-12-31 | 0.00% 10-K · filed 2024-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Lyell Immunopharma, Inc. (LYEL) | United States | $0.248B | -1.32 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Akebia Therapeutics, Inc. (AKBA) | United States | $0.255B | -10.35 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |